Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Interest Expenses (2016 - 2025)

Orthopediatrics has reported Interest Expenses over the past 6 years, most recently at $1.9 million for Q4 2025.

  • Quarterly results put Interest Expenses at $1.9 million for Q4 2025, up 46.47% from a year ago — trailing twelve months through Dec 2025 was $6.0 million (up 128.77% YoY), and the annual figure for FY2025 was $6.0 million, up 128.77%.
  • Interest Expenses for Q4 2025 was $1.9 million at Orthopediatrics, up from $1.8 million in the prior quarter.
  • Over the last five years, Interest Expenses for KIDS hit a ceiling of $1.9 million in Q4 2025 and a floor of -$303000.0 in Q4 2023.
  • Median Interest Expenses over the past 3 years was $637000.0 (2024), compared with a mean of $784454.5.
  • Peak annual rise in Interest Expenses hit 1823.81% in 2024, while the deepest fall reached 11.22% in 2024.
  • Orthopediatrics' Interest Expenses stood at -$303000.0 in 2023, then skyrocketed by 535.31% to $1.3 million in 2024, then skyrocketed by 46.47% to $1.9 million in 2025.
  • The last three reported values for Interest Expenses were $1.9 million (Q4 2025), $1.8 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.